Nab-paclitaxel or docetaxel; as alternatives to...

Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK)

G. Dranitsaris, M. Lidgren, J. Lundkvist, R. Coleman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70374-4
File:
PDF, 60 KB
english, 2008
Conversion to is in progress
Conversion to is failed